Premium
Eslicarbazepine: new adjunctive treatment for partial epilepsy
Author(s) -
Chaplin Steve,
Kelso Andrew
Publication year - 2010
Publication title -
prescriber
Language(s) - English
Resource type - Journals
SCImago Journal Rank - 0.106
H-Index - 3
eISSN - 1931-2253
pISSN - 0959-6682
DOI - 10.1002/psb.600
Subject(s) - medicine , adjunctive treatment , epilepsy , adverse effect , antiepileptic drug , intensive care medicine , psychiatry , pharmacology
Eslicarbazepine acetate (Zebinix) is a new antiepileptic drug licensed as adjunctive treatment for partialonset seizures. In our New products review, Steve Chaplin presents the clinical data relating to efficacy and adverse effects, and Dr Andrew Kelso discusses its potential role in epilepsy treatment. Copyright © 2010 Wiley Interface Ltd